Efficacy of Mirabegron Add-on Therapy to Oxybutynin for BPH Patients with Persistent Urgency on Oxybutynin Alone

1Ali Mohammed Abdulameer, Ali Abdulbaqi Ali Ismael, Osamah Mohammed Aldaghir and Bashar Adnan Munshid

146 Views
20 Downloads
Abstract:

Aims: To compare the efficacy of mirabegron add-on therapy for persistent overactive bladder (OAB) symptoms despite oxybutynin monotherapy in men with irritative lower urinary tract symptoms suggestive of benign prostatic hyperplasia Methods: 50 patients with persistent irritative lower urinary tract symptoms despite Ditropan monotherapy were randomized to receive add-on therapy with mirabegron (50 mg/day) for 3 months. Improvement in IPSS score and QOL were assessed in patients before and after addition of mirabegron at 3 months Result: From September 2018 to December 2019, 50 patients were enrolled in this study. 38 out of 50 patient got improvement in quality of life (QOL) score. The IPSS score had a mean improvement from 16.6 before addition of mirabegron to 12.68 after 12 weeks of mirabegrone addition. Conclusions: In our study, we noticed that the add-on mirabegron to patients already on anticholinergic drugs but still with persistent irritative LUTS had get good imapact on IPSS score and QOL.

Keywords:

Mirabegron, Therapy, Oxybutynin, BPH.

Paper Details
Month3
Year2020
Volume24
IssueIssue 5
Pages929-933